In breast cancer, expression of c Kit is reported to be reduced and detected in 1–13% of tumours (Tsuura et al, 2002; Nielsen et al, 2004; Simon et al, 2004; Tsuda et al, 2005; Reis-Filho and Tutt, 2008). Here, KIT is linked to breast carcinoma.